Anti-angiogenesis in Personalized Therapy of Lung Cancer.
about
Ginsenoside Rg3 Serves as an Adjuvant Chemotherapeutic Agent and VEGF Inhibitor in the Treatment of Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review.Strategies targeting angiogenesis in advanced non-small cell lung cancer.Microvascular proliferation is associated with aggressive tumour features and reduced survival in lung adenocarcinoma.
P2860
Anti-angiogenesis in Personalized Therapy of Lung Cancer.
description
2016 nî lūn-bûn
@nan
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
name
Anti-angiogenesis in Personalized Therapy of Lung Cancer.
@en
type
label
Anti-angiogenesis in Personalized Therapy of Lung Cancer.
@en
prefLabel
Anti-angiogenesis in Personalized Therapy of Lung Cancer.
@en
P2860
P1476
Anti-angiogenesis in Personalized Therapy of Lung Cancer.
@en
P2093
Peter M Ellis
P2860
P304
P356
10.1007/978-3-319-24223-1_5
P407
P577
2016-01-01T00:00:00Z